Compare LIVE & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LIVE | CCEL |
|---|---|---|
| Founded | 1968 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Managed Health Care |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.3M | 32.7M |
| IPO Year | N/A | 1997 |
| Metric | LIVE | CCEL |
|---|---|---|
| Price | $14.00 | $4.01 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 12.2K | 3.5K |
| Earning Date | 12-11-2025 | 10-15-2025 |
| Dividend Yield | N/A | ★ 10.34% |
| EPS Growth | N/A | N/A |
| EPS | ★ 4.93 | N/A |
| Revenue | ★ $444,944,000.00 | $31,747,500.00 |
| Revenue This Year | N/A | $0.30 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $2.84 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.25 | $3.57 |
| 52 Week High | $25.88 | $8.79 |
| Indicator | LIVE | CCEL |
|---|---|---|
| Relative Strength Index (RSI) | 64.17 | 47.33 |
| Support Level | $9.05 | $3.81 |
| Resistance Level | $17.35 | $4.38 |
| Average True Range (ATR) | 1.55 | 0.27 |
| MACD | 0.77 | 0.01 |
| Stochastic Oscillator | 70.33 | 50.23 |
Live Ventures Inc is a holding company for diversified businesses. It is focused on acquiring and operating profitable companies in various industries. The company operates in the business segments of Retail Entertainment which includes direct sales of entertainment and appliance products and services, Flooring Manufacturing, Steel Manufacturing, which includes the sale of steel plates, ground flat stock, and drill rods, and Corporate and Other. It derives key revenue from the Flooring Manufacturing segment which includes the manufacturing of carpets and rugs, yarn products, as well as a reseller of hard surface flooring products. Geographically the activities are carried out throughout the United States.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.